Unknown

Dataset Information

0

Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study.


ABSTRACT: BACKGROUND:Bacillus Calmette-Guérin (BCG) vaccination may have beneficial non-specific effects on child survival, the effects being stronger for children developing a scar. In a prospective cohort study, we examined determinants for not developing a BCG scar within 6 months of vaccination. METHODS:Bandim Health Project (BHP) runs a Health and Demographic Surveillance System site in rural Guinea-Bissau. BHP provides BCG at monthly visits. We studied determinants for not developing a BCG scar using binomial regression models to obtain relative risks (RR). RESULTS:From May 2012 until October 2014, BHP nurses vaccinated 2415 infants with BCG. We assessed BCG scar between 6 and 12 months of age for 2156 (89%) of these children and 2115 (98%) had developed a scar. In comparison, among 785 children BCG vaccinated elsewhere, 622 (79%) had a scar, the RR of not having a scar being 10.91 (7.52-15.85) compared with children vaccinated by BHP. Among children vaccinated by BHP, those receiving the Russian BCG strain were more likely not to develop a scar (RR = 2.98 (1.52-5.81)) compared with children receiving Danish BCG strain. Children with no post-injection wheal or a wheal <3 mm were more likely to not develop a scar (RR = 9.05 (3.69-22.20) and RR = 4.74 (1.96-11.45), respectively). Nutritional status and socioeconomic status were not associated with scarification. CONCLUSION:Vaccination technique and vaccine strain were associated with BCG scar development while nutritional status and socioeconomic status were not. Scarring rate may therefore be a better indicator of vaccination programme performance than coverage.

SUBMITTER: Funch KM 

PROVIDER: S-EPMC6284494 | biostudies-other | 2018

REPOSITORIES: biostudies-other

altmetric image

Publications

Determinants of BCG scarification among children in rural Guinea-Bissau: A prospective cohort study.

Funch Katarina M KM   Thysen Sanne M SM   Rodrigues Amabelia A   Martins Cesario L CL   Aaby Peter P   Benn Christine S CS   Fisker Ane B AB  

Human vaccines & immunotherapeutics 20180123 10


<h4>Background</h4>Bacillus Calmette-Guérin (BCG) vaccination may have beneficial non-specific effects on child survival, the effects being stronger for children developing a scar. In a prospective cohort study, we examined determinants for not developing a BCG scar within 6 months of vaccination.<h4>Methods</h4>Bandim Health Project (BHP) runs a Health and Demographic Surveillance System site in rural Guinea-Bissau. BHP provides BCG at monthly visits. We studied determinants for not developing  ...[more]

Similar Datasets

| S-EPMC8212457 | biostudies-literature
| S-EPMC4195857 | biostudies-other
| S-EPMC3532986 | biostudies-literature
| S-EPMC3329603 | biostudies-literature
| S-EPMC5811910 | biostudies-literature
| S-EPMC4645958 | biostudies-literature
| S-EPMC7416537 | biostudies-literature
| S-EPMC6773322 | biostudies-literature
| S-EPMC2839082 | biostudies-literature
| S-EPMC3599523 | biostudies-literature